查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571693

筆式注射器市場規模、佔有率、趨勢分析報告：按產品、應用、最終用途、地區和細分市場進行預測，2024-2030 年

Injection Pen Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Osteoporosis, Diabetes Anaphylaxis), By End-use (Hospitals), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

筆式注射器市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球筆式注射器市場規模預計將達到607.2億美元，預測期內複合年成長率為7.2%。

對這些用於治療各種慢性和急性疾病的設備的高需求以及新興市場意識的不斷提高是預計推動市場的主要因素。

筆式注射器在提高慢性病治療患者的便利性方面取得了巨大成功。這些設備比其他輸送系統更方便、更實惠。持續研究評估其在其他疾病（包括但不限於丙型肝炎和癌症）管理中的應用，預計將在 2025 年推動市場快速成長。

筆式注射器市場報告亮點

  • 糖尿病和關節炎等疾病盛行率的上升主要推動了市場的成長。
  • 該市場受到已開發經濟體和新興經濟體政府醫療保健支出增加以及有利的醫療保險政策的推動。
  • 從產品來看，可重複使用筆式注射器是最大且成長最快的細分市場，因為可重複使用筆式注射器具有成本效益和患者便利性等優勢。市面上可重複使用的筆式注射器主要有NovoPen、Luxra、BerriPen、Allstar、NovoRapid、Vasargar、Byduron、 Epipen、 Genotropin等。
  • 北美佔據市場主導地位，其次是歐洲。技術進步以及骨質疏鬆症、關節炎和過敏反應發病率的增加是獲得最大市場佔有率的因素。
  • 預計亞太地區將成為預測期內成長最快的地區。在該地區，醫療保健服務的改善以及醫療保健成本的持續增加正在推動市場的成長。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章全球筆式注射器市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 全球筆式注射器市場分析工具
    • 波特的分析
    • PESTEL分析

第4章全球筆式注射器市場：產品預估及趨勢分析

  • 細分儀表板
  • 筆式注射器市場：2023 年和 2030 年產品變化分析
  • 一次性的
  • 可重複使用的

第5章全球筆式注射器市場：應用預估及趨勢分析

  • 細分儀表板
  • 筆式注射器市場：2023 年和 2030 年應用變化分析
  • 糖尿病
  • 過敏反應
  • 骨質疏鬆症
  • 生長激素缺乏症
  • 關節炎
  • 其他

第6章 手套筆式注射器市場：最終用途估計與趨勢分析

  • 細分儀表板
  • 筆式注射器市場：2023 年和 2030 年最終用途變化分析
  • 醫院
  • 診所
  • 居家照護環境

第7章 手套筆注射器市場：區域估計與趨勢分析

  • 2023 年和 2030 年筆式注射器市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 科威特

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • BD
    • Lilly
    • Ypsomed AG
    • Biocon
    • Pfizer Inc.
    • Novartis AG
    • Novo Nordisk A/S
    • Sanofi
    • Owen Mumford Ltd.
    • Merck KGaA
簡介目錄
Product Code: GVR-2-68038-445-1

Injection Pen Market Growth & Trends:

The global injection pen market size is expected to reach USD 60.72 billion by 2030, according to a new report by Grand View Research, Inc., registering a 7.2% CAGR during the forecast period. High demand for these devices for management of various chronic as well as acute diseases and increasing awareness in developing regions are key factors expected to drive the market.

Injectable pens have witnessed significant success in improving patient convenience during management of chronic disease, a process that might include administering intermittent injections. These devices are more convenient and affordable than other delivery systems. Ongoing studies on the same to assess their applications in management of other diseases, including but not limited to Hepatitis C and cancer, is expected to ensure swift market growth through 2025.

Injection Pen Market Report Highlights:

  • Rising incidence of diseases such as diabetes and arthritis is primarily boosting market growth
  • Increase in government healthcare expenditure and availability of favorable healthcare insurance policies in developed as well as developing countries is driving the market
  • By product, reusable injectable pens are the largest and fastest growing segment owing to the advantages associated with them such as cost effectiveness and patient convenience. Commercially available reusable injectable pens mainly include Novopen, Luxura, Berlipen, AllStar, NovoRapid, basalgar, Bydureon, Epipen and Genotropin
  • North America dominates the market, followed by Europe. Technological advancements and increase in incidence of osteoporosis, arthritis, and anaphylaxis are factors that can be attributable to its largest market share
  • Asia Pacific is expected to be the fastest growing region over the forecast period. Better accessibility to healthcare, coupled with constantly increasing healthcare expenditure in the region, is fueling market growth

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Injection Pen Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Global Injection Pen Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Global Injection Pen Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Injection Pen Market: Product Movement Analysis, 2023 & 2030 (USD Billion)
  • 4.3. Disposable
    • 4.3.1. Disposable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Reusable
    • 4.4.1. Reusable Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Global Injection Pen Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Injection Pen Market: Application Movement Analysis, 2023 & 2030 (USD Billion)
  • 5.3. Diabetes
    • 5.3.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Anaphylaxis
    • 5.4.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Osteoporosis
    • 5.5.1. Osteoporosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Growth Hormone Deficiency
    • 5.6.1. Growth hormone deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Arthritis
    • 5.7.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Globe Injection Pen Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Injection Pen Market: End Use Movement Analysis, 2023 & 2030 (USD Billion)
  • 6.3. Hospitals
    • 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Clinics
    • 6.4.1. Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Home Care Settings
    • 6.5.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Globe Injection Pen Market: Regional Estimates & Trend Analysis

  • 7.1. Injection Pen Market Share, By Region, 2023 & 2030 (USD Billion)
  • 7.2. North America
    • 7.2.1. North America Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. U.K.
      • 7.3.2.1. U.K. Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. Italy
      • 7.3.4.1. Italy Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Denmark
      • 7.3.6.1. Denmark Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Sweden
      • 7.3.7.1. Sweden Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. South Africa
      • 7.6.4.1. South Africa Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. Kuwait
      • 7.6.5.1. Kuwait Injection Pen Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. BD
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Lilly
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Ypsomed AG
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Biocon
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Pfizer Inc.
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Novartis AG
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Novo Nordisk A/S
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Sanofi
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Owen Mumford Ltd.
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Merck KGaA
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives